• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

夫西地酸单独及与其他抗生素联合对甲氧西林敏感和耐药金黄色葡萄球菌的体外抗菌活性。

In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.

作者信息

Drugeon H B, Caillon J, Juvin M E

机构信息

CERMIA, Menton, France.

出版信息

J Antimicrob Chemother. 1994 Dec;34(6):899-907. doi: 10.1093/jac/34.6.899.

DOI:10.1093/jac/34.6.899
PMID:7730233
Abstract

The activity of fusidic acid alone and in combination with gentamicin, oxacillin, rifampicin, fosfomycin and ciprofloxacin was investigated against 36 strains of Staphylococcus aureus. The fusidic acid MIC50 of 0.06 mg/L and MIC90 of 0.125 mg/L were determined for 36 strains. Bactericidal activity of fusidic acid was confirmed. Several types of interaction were observed with other antibiotics: dominant effect of fusidic acid over gentamicin; synergy with rifampicin for three or four strains; indifference or dominance with oxacillin, indifference with vancomycin, indifference or dominance with fosfomycin, and indifference with ciprofloxacin. Antagonism was seen with only one strain, following exposure to fusidic acid and rifampicin.

摘要

研究了夫西地酸单独以及与庆大霉素、苯唑西林、利福平、磷霉素和环丙沙星联合使用时对36株金黄色葡萄球菌的活性。测定了36株菌的夫西地酸MIC50为0.06mg/L,MIC90为0.125mg/L。证实了夫西地酸的杀菌活性。观察到与其他抗生素有几种相互作用类型:夫西地酸对庆大霉素的主导作用;与利福平对三或四株菌有协同作用;与苯唑西林无相互作用或夫西地酸占主导;与万古霉素无相互作用;与磷霉素无相互作用或夫西地酸占主导;与环丙沙星无相互作用。仅在一株菌中观察到夫西地酸和利福平联合使用时有拮抗作用。

相似文献

1
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.夫西地酸单独及与其他抗生素联合对甲氧西林敏感和耐药金黄色葡萄球菌的体外抗菌活性。
J Antimicrob Chemother. 1994 Dec;34(6):899-907. doi: 10.1093/jac/34.6.899.
2
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.利奈唑胺与万古霉素、庆大霉素、环丙沙星、夫西地酸和利福平联合应用对金黄色葡萄球菌的体外杀菌活性。
Antimicrob Agents Chemother. 2003 Jan;47(1):418-20. doi: 10.1128/AAC.47.1.418-420.2003.
3
Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.耐甲氧西林和庆大霉素的金黄色葡萄球菌:对磷霉素、头孢孟多、N-甲酰亚胺硫霉素、克林霉素、夫西地酸和万古霉素的敏感性
Drugs Exp Clin Res. 1985;11(1):23-7.
4
In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.环丙沙星联合夫西地酸或利福平对金黄色葡萄球菌的体外活性。
J Antimicrob Chemother. 1989 Mar;23(3):347-52. doi: 10.1093/jac/23.3.347.
5
In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.万古霉素、利福平及夫西地酸单独及联合使用对耐甲氧西林金黄色葡萄球菌的体外作用
J Antimicrob Chemother. 1983 Jan;11(1):21-6. doi: 10.1093/jac/11.1.21.
6
In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.达托霉素联合利福平、庆大霉素、磷霉素和夫西地酸对耐甲氧西林金黄色葡萄球菌的体外活性。
J Glob Antimicrob Resist. 2017 Sep;10:223-227. doi: 10.1016/j.jgar.2017.05.022. Epub 2017 Jul 19.
7
The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.某些抗菌剂对耐甲氧西林金黄色葡萄球菌的体外活性。
J Antimicrob Chemother. 1985 Mar;15(3):291-5. doi: 10.1093/jac/15.3.291.
8
Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.替考拉宁和万古霉素联合利福平、夫西地酸或磷霉素对静脉导管上葡萄球菌的抗菌活性
Scand J Infect Dis Suppl. 1990;72:14-9.
9
Staphylococcus aureus resistance to antibiotics and spread of phage types.金黄色葡萄球菌对抗生素的耐药性及噬菌体类型的传播。
Medicina (Kaunas). 2006;42(4):332-9.
10
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.金黄色葡萄球菌对夫西地酸和利福平耐药的突变频率。
J Antimicrob Chemother. 2001 May;47(5):647-50. doi: 10.1093/jac/47.5.647.

引用本文的文献

1
Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies.磷霉素作为全身感染管理的联合用药。对其体外和体内研究协同特性的系统评价。
Antibiotics (Basel). 2020 Aug 10;9(8):500. doi: 10.3390/antibiotics9080500.
2
Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in Static and Dynamic Models.抗葡萄球菌抗生素与夫西地酸联合应用对静态和动态模型中葡萄球菌生物膜的活性。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00598-18. Print 2018 Jul.
3
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.
磷霉素与其他抗生素对革兰氏阳性菌和革兰氏阴性菌的协同作用。
Eur J Clin Pharmacol. 2010 Apr;66(4):359-68. doi: 10.1007/s00228-010-0794-5. Epub 2010 Feb 26.